Applied Materials (AMAT) CEO comments that the company now expects overall packaging revenues to grow more than 70% and expects to grow process diagnostics and control business over 50% in calendar 2026
Newsquawk Staff ·
Have strong pipeline of new process diagnostics and control products that will fuel growth in 2027 and beyond.
CFO says expect very significant increase in DRAM revenues in the second half of calendar 2026 as customers begin to expand clean room capacity.
What it means
Segment-level forward guidance of this kind is how semicap managements have historically framed an upcycle: leading with the fastest-growing niche, here advanced packaging, rather than consolidated revenue, because packaging and process control are where wafer fab equipment vendors have been gaining wallet share as chip architectures shift toward heterogenous integration. The DRAM comment fits an established sequence in memory cycles, where cleanroom expansion announcements precede equipment orders by several quarters, so a second-half revenue inflection guided now is consistent with customers committing capacity ahead of an expected supply tightness. The distinction worth drawing is between guidance anchored to specific capacity additions, which tends to be more durable, and guidance resting on broad demand optimism, which has historically been the first line cut when orders pause. Peers in the wafer fab equipment complex have typically traded as a group on read-throughs of this kind, particularly where DRAM exposure overlaps. Follow-ons are the formal print and the order and backlog disclosures, where the credibility of the calendar 2026 ramp will show up first, and any corroborating capacity commentary from the memory makers themselves.
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS
- Newsquawk Weekly Economic Release 26th - 30th October 2026
Related headlines
- OpenAI reveals plans for an in-house exabyte-scale storage system7 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter8 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)9 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed9 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce10 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders10 hours ago
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease4 hours ago
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL6 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 20277 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability8 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer10 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation11 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM11 hours ago
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years12 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months12 hours ago